150 related articles for article (PubMed ID: 34530776)
1. Body mass index in relation to prostate-specific antigen-related parameters.
Lin D; Liu T; Chen L; Chen Z
BMC Urol; 2021 Sep; 21(1):130. PubMed ID: 34530776
[TBL] [Abstract][Full Text] [Related]
2. Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China.
Zhang J; Ma M; Nan X; Sheng B
Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27409334
[TBL] [Abstract][Full Text] [Related]
3. Relationship between body mass index and concentrations of prostate specific antigen: a cross-sectional study.
Zhao Y; Zhang Y; Wang X; Lin D; Chen Z
Scand J Clin Lab Invest; 2020; 80(2):162-167. PubMed ID: 31855065
[TBL] [Abstract][Full Text] [Related]
4. The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection.
Wallner LP; Morgenstern H; McGree ME; Jacobson DJ; St Sauver JL; Jacobsen SJ; Sarma AV
Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):501-8. PubMed ID: 21242331
[TBL] [Abstract][Full Text] [Related]
5. Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk.
Bonn SE; Sjölander A; Tillander A; Wiklund F; Grönberg H; Bälter K
Int J Cancer; 2016 Jul; 139(1):50-7. PubMed ID: 26914149
[TBL] [Abstract][Full Text] [Related]
6. Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study.
Chia SE; Lau WK; Chin CM; Tan J; Ho SH; Lee J; Cheng C
BJU Int; 2009 Jun; 103(11):1487-91. PubMed ID: 19076145
[TBL] [Abstract][Full Text] [Related]
7. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between serum prostate-specific antigen levels and body mass index in Beijing men over 50 years of age].
Wang Y; Zhou Z; Tian Y; Shao Q; Chen S; Hong BF; Zhang XH; Ren XH; Sun WX; Wang ZW; Na YQ
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1681-3. PubMed ID: 19957525
[TBL] [Abstract][Full Text] [Related]
9. [Association between obesity-related plasma hemodilution and the concentration of prostate specific antigen].
Li F; Yin X; Li D; Yin Z; Qi S; Shi H; Gao J; Zhang X
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1721-4. PubMed ID: 26714904
[TBL] [Abstract][Full Text] [Related]
10. Obesity and screening PSA levels among men undergoing an annual physical exam.
Rundle A; Neugut AI
Prostate; 2008 Mar; 68(4):373-80. PubMed ID: 18189231
[TBL] [Abstract][Full Text] [Related]
11. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
12. Relationship between prostate-specific antigen and obesity in prostate cancer screening: analysis of a large cohort in Japan.
Kubota Y; Seike K; Maeda S; Shinohara Y; Iwata M; Sugimoto N
Int J Urol; 2011 Jan; 18(1):72-5. PubMed ID: 21198939
[TBL] [Abstract][Full Text] [Related]
13. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
[TBL] [Abstract][Full Text] [Related]
14. Serum prostate-specific antigen concentration and hemodilution among Chinese middle-aged obese men: a hematocrit-based equation for plasma volume estimation is induced.
Li F; Shen Z; Lu Y; Yun J; Fan Y
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1731-4. PubMed ID: 22850805
[TBL] [Abstract][Full Text] [Related]
15. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
[TBL] [Abstract][Full Text] [Related]
16. Which obesity index best correlates with prostate volume, prostate-specific antigen, and lower urinary tract symptoms?
Yang HJ; Doo SW; Yang WJ; Song YS
Urology; 2012 Jul; 80(1):187-90. PubMed ID: 22626573
[TBL] [Abstract][Full Text] [Related]
17. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
18. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
Bañez LL; Hamilton RJ; Partin AW; Vollmer RT; Sun L; Rodriguez C; Wang Y; Terris MK; Aronson WJ; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
JAMA; 2007 Nov; 298(19):2275-80. PubMed ID: 18029831
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal changes in prostate volume in a community-based cohort study of middle-aged and elderly men in rural China.
Liang QF; Zhang SC; Yu XH; Li JH; Zheng JB; Zhao J; Liang GQ; Shi HJ; Zhou WJ; Zhu QX
Andrology; 2020 Mar; 8(2):358-363. PubMed ID: 31539457
[TBL] [Abstract][Full Text] [Related]
20. Trends and co-trends of prostate-specific antigen and body mass index in a screened population.
Ankerst DP; Pollock BH; Liang Y; Dizdarevic N; Kyrylenko S; Boeck A; Thompson IM; Leach R
Urology; 2011 Jul; 78(1):10-6. PubMed ID: 21550639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]